Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents

  • Liqiang Su
  • , Jiahui Li
  • , Zhen Zhou
  • , Dongxia Huang
  • , Yuanjin Zhang
  • , Haixiang Pei
  • , Weikai Guo
  • , Haigang Wu
  • , Xin Wang
  • , Mingyao Liu
  • , Cai Guang Yang
  • , Yihua Chen*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Several 6-substituted tetrahydrocarbazole derivatives were designed, synthesized and evaluated for the antibacterial activities against Staphylococcus aureus Newman strain. Subsequently, 2,4-diaminopyrimidine scaffold was merged with the tetrahydrocarbazole unit to generate a series of novel hybrid derivatives and the antibacterial activities were also investigated. Among these novel hybrids, compound 12c showed the most potent activity with a MIC of 0.39–0.78 μg/mL against S. aureus Newman and Escherichia coli AB1157 strain. In addition, compound 12c exhibited low MIC values against a panel of multidrug-resistant strains of S. aureus.

Original languageEnglish
Pages (from-to)203-211
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Volume162
DOIs
StatePublished - 15 Jan 2019

Keywords

  • 2,4-diaminopyrimidine
  • Antibacterial activities
  • Multidrug-resistance
  • Structure-activity relationship
  • Tetrahydrocarbazole

Fingerprint

Dive into the research topics of 'Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents'. Together they form a unique fingerprint.

Cite this